LINADIB 5 MG COM REV CT BL AL AL X 60
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1023512590030 -
GGREM
541820080137807 -
Código de barras
7896004772387 -
Código de barras
7896004787534
O que a fonte publica
- Detentor do registro
- EMS S/A
- Princípios ativos
- LINAGLIPTINA
- Embalagem
- 5 MG COM REV CT BL AL AL X 60
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Similar
- Classe terapêutica
- A10N1 - ANTIDIABÉTICOS INIBIDORES DPP-IV PUROS
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "LINADIB 5 MG COM REV CT BL AL AL X 60",
"holder": "EMS S/A",
"stripe": "Tarja Vermelha",
"barcodes": [
"7896004772387",
"7896004787534"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "541820080137807",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "57.507.378/0003-65",
"priceRegime": "Regulado",
"productName": "LINADIB",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "5 MG COM REV CT BL AL AL X 60",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "410.05",
"icms-12": "465.97",
"icms-17": "494.04",
"icms-18": "500.06",
"icms-19": "506.23",
"icms-20": "512.56",
"icms-21": "519.05",
"icms-22": "525.71",
"icms-23": "532.53",
"icms-17.5": "497.03",
"icms-19.5": "509.38",
"icms-20.5": "515.79",
"icms-22.5": "529.10",
"icms-12-alc": "416.04",
"icms-17-alc": "441.10",
"icms-18-alc": "446.48",
"icms-19-alc": "451.99",
"icms-20-alc": "457.64",
"icms-21-alc": "463.44",
"icms-22-alc": "469.38",
"icms-23-alc": "475.48",
"withoutTaxes": "366.12",
"icms-17.5-alc": "443.78",
"icms-19.5-alc": "454.80",
"icms-20.5-alc": "460.52",
"icms-22.5-alc": "472.41"
},
"pisCofinsList": "Negativa",
"substanceText": "LINAGLIPTINA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "550.07",
"icms-12": "625.08",
"icms-17": "662.74",
"icms-18": "670.81",
"icms-19": "679.09",
"icms-20": "687.58",
"icms-21": "696.29",
"icms-22": "705.22",
"icms-23": "714.37",
"icms-17.5": "666.75",
"icms-19.5": "683.32",
"icms-20.5": "691.91",
"icms-22.5": "709.77",
"icms-12-alc": "575.15",
"icms-17-alc": "609.79",
"icms-18-alc": "617.23",
"icms-19-alc": "624.85",
"icms-20-alc": "632.66",
"icms-21-alc": "640.68",
"icms-22-alc": "648.89",
"icms-23-alc": "657.32",
"withoutTaxes": "506.13",
"icms-17.5-alc": "613.50",
"icms-19.5-alc": "628.73",
"icms-20.5-alc": "636.64",
"icms-22.5-alc": "653.08"
},
"invalidBarcodes": [],
"activeSubstances": [
"LINAGLIPTINA"
],
"therapeuticClass": "A10N1 - ANTIDIABÉTICOS INIBIDORES DPP-IV PUROS",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1023512590030",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "A10N1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:541820080137807"